FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jörgen Carlsson

Research Profile

Anatomy

Disorders

Chemicals & Drugs

Procedures

Boron Neutron Capture Therapy

Concepts & Ideas

Tissue Distribution

Physiology

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Jörgen Carlsson
Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors.
O F Qvarnström; Maria Simonsson; Jörgen Carlsson; T A Tran
Effects of affinity on binding of HER2-targeting Affibody molecules: model experiments in breast cancer spheroids.
Erika Nordberg; L Ekerljung; S H Sahlberg; Jörgen Carlsson; Johan Lennartsson; Bengt Glimelius
Effects of an EGFR-binding affibody molecule on intracellular signaling pathways.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jörgen Carlsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jörgen Carlsson
Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(3):653-9.
2011: O F Qvarnström; Maria Simonsson; Jörgen Carlsson; T A Tran
Effects of affinity on binding of HER2-targeting Affibody molecules: model experiments in breast cancer spheroids.
International journal of oncology 2011;39(2):353-9.
2010: Erika Nordberg; L Ekerljung; S H Sahlberg; Jörgen Carlsson; Johan Lennartsson; Bengt Glimelius
Effects of an EGFR-binding affibody molecule on intracellular signaling pathways.
International journal of oncology 2010;36(4):967-72.
2010: Lovisa Göstring; Ming Tsuey Chew; Anna Orlova; Ingmarie Höidén Guthenberg; Anders Wennborg; Jörgen Carlsson; Fredrik Y Frejd
Quantification of internalization of EGFR-binding Affibody molecules: Methodological aspects.
International journal of oncology 2010;36(4):757-63.
2010: Amelie Fondell; Katarina Edwards; Ludger M Ickenstein; Stefan Sjöberg; Jörgen Carlsson; Lars Gedda
Nuclisome: a novel concept for radionuclide therapy using targeting liposomes.
European journal of nuclear medicine and molecular imaging 2010;37(1):114-23.
2009: O F Qvarnström; Maria Simonsson; V Eriksson; Ingela Turesson; Jörgen Carlsson
gammaH2AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT474 cellular spheroids.
International journal of oncology 2009;35(1):41-7.
2008: Lina Ekerljung; Malin Lindborg; Lars Gedda; Fredrik Y Frejd; Jörgen Carlsson; Johan Lennartsson
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line.
Biochemical and biophysical research communications 2008;377(2):489-94.
2008: Lova Segerström; Bo Stenerlow; Veronika Eriksson; Jörgen Carlsson
Effects of radiation on growth of two human tumour cell lines surviving a previous high dose, low dose-rate, radionuclide exposure.
International journal of oncology 2008;33(2):341-9.
2008: Ann-Charlott Steffen; Lovisa Göstring; Vladimir Tolmachev; Stig Palm; Bo Stenerlöw; Jörgen Carlsson
Differences in radiosensitivity between three HER2 overexpressing cell lines.
European journal of nuclear medicine and molecular imaging 2008;35(6):1179-91.
2008: S A Enger; T Hartman; Jörgen Carlsson; Hans Lundqvist
Cross-fire doses from beta-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristics.
Physics in medicine and biology 2008;53(7):1909-20.
2008: E Nordberg; Anna Orlova; M Friedman; Vladimir Tolmachev; S Ståhl; F Y Nilsson; B Glimelius; Jörgen Carlsson
In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells.
Oncology reports 2008;19(4):853-7.
2007: Erika Nordberg; Mikaela Friedman; Lovisa Göstring; Gregory P Adams; hjalmar brismar; Fredrik Y Nilsson; Stefan Ståhl; Bengt Glimelius; Jörgen Carlsson
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.
Nuclear medicine and biology 2007;34(6):609-18.
2007: Ann-Charlott Steffen; Ylva Almqvist; Ming-Kuan Chyan; Hans Lundqvist; Vladimir Tolmachev; D Scott Wilbur; Jörgen Carlsson
Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
Oncology reports 2007;17(5):1141-7.
2007: Vladimir Tolmachev; Anna Orlova; Rikard Pehrson; Joakim Galli; Barbro Baastrup; Karl Andersson; Mattias Sandström; Daniel Rosik; Jörgen Carlsson; Hans Lundqvist; Anders Wennborg; Fredrik Y Nilsson
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
Cancer research 2007;67(6):2773-82.
2007: Azita Monazzam; Raymond Josephsson; Carl Blomqvist; Jörgen Carlsson; Bengt Långström; Mats Bergström
Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer.
Breast cancer research : BCR 2007;9(4):R45.
2007: Mikael Persson; Lars Gedda; Hans Lundqvist; Vladimir Tolmachev; Hans Nordgren; Per-Uno Malmstrom; Jörgen Carlsson
[177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts.
Cancer research 2007;67(1):326-31.
2006: Jörgen Carlsson; Veronika Eriksson; Bo Stenerlöw; Hans Lundqvist
Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
European journal of nuclear medicine and molecular imaging 2006;33(10):1185-95.
2006: Ludger M Ickenstein; Katarina Edwards; Stefan Sjöberg; Jörgen Carlsson; Lars Gedda
A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy.
Nuclear medicine and biology 2006;33(6):773-83.
2006: Ann-Charlott Steffen; Anna Orlova; Maria Wikman; Fredrik Y Nilsson; Stefan Ståhl; Gregory P Adams; Vladimir Tolmachev; Jörgen Carlsson
Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice.
European journal of nuclear medicine and molecular imaging 2006;33(6):631-8.
2006: Anna Orlova; Mikaela Magnusson; Tove L J Eriksson; Martin Nilsson; Barbro Larsson; Ingmarie Höidén Guthenberg; Charles Widström; Jörgen Carlsson; Vladimir Tolmachev; Stefan Ståhl; Fredrik Y Nilsson
Tumor imaging using a picomolar affinity HER2 binding affibody molecule.
Cancer research 2006;66(8):4339-48.
2006: Anna Orlova; Fredrik Y Nilsson; Maria Wikman; Charles Widström; Stefan Ståhl; Jörgen Carlsson; Vladimir Tolmachev
Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):512-9.
2006: Jörgen Carlsson; Zhi-Ping Ren; Kenneth Wester; Asa Liljegren Sundberg; Nils-Erik Heldin; Göran Hesselager; Mikael Persson; Lars Gedda; Vladimir Tolmachev; Hans Lundqvist; Erik Blomquist; Monica Nistér
Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.
Journal of neuro-oncology 2006;77(1):33-45.
2006: Lina Ekerljung; Ann-Charlott Steffen; Jörgen Carlsson; Johan Lennartsson
Effects of HER2-binding affibody molecules on intracellular signaling pathways.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(4):201-10.
2005: Mikael Persson; Vladimir Tolmachev; Karl Andersson; Lars Gedda; Mattias Sandström; Jörgen Carlsson
[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.
European journal of nuclear medicine and molecular imaging 2005;32(12):1457-62.
2005: Irina Velikyan; Asa Liljegren Sundberg; Orjan Lindhe; A Urban Höglund; Olof Eriksson; Eva Werner; Jörgen Carlsson; Mats Bergström; Bengt Långström; Vladimir Tolmachev
Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(11):1881-8.
2005: Erika Nordberg; Ann-Charlott Steffen; Mikael Persson; Asa Liljegren Sundberg; Jörgen Carlsson; Bengt Glimelius
Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.
European journal of nuclear medicine and molecular imaging 2005;32(7):771-7.
2005: Ann-Charlott Steffen; Maria Wikman; Vladimir Tolmachev; Gregory P Adams; Fredrik Y Nilsson; Stefan Ståhl; Jörgen Carlsson
In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.
Cancer biotherapy & radiopharmaceuticals 2005;20(3):239-48.
2005: Truls Gårdmark; Kenneth Wester; Manuel de la Torre; Jörgen Carlsson; Per-Uno Malmstrom
Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.
BJU international 2005;95(7):982-6.
2004: Anna Orlova; Anna Sjöstrom; Ondrej Lebeda; Hans Lundqvist; Jörgen Carlsson; Vladimir Tolmachev
Targeting against epidermal growth factor receptors. Cellular processing of astatinated EGF after binding to cultured carcinoma cells.
Anticancer research 2004;24(6):4035-41.
2004: Vladimir Tolmachev; Anna Orlova; Qichun Wei; Alexander Bruskin; Jörgen Carlsson; Lars Gedda
Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):491-501.
2004: Asa Liljegren Sundberg; Lars Gedda; Anna Orlova; Alexander Bruskin; Erik Blomquist; Jörgen Carlsson; Vladimir Tolmachev
[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):195-204.
2004: Hans Lundqvist; Jörgen Carlsson; Lars Gedda; Vladimir Tolmachev; Ulrike Garske; Kalevi Kairemo
[Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use].
Läkartidningen 2004;101(11):1000-2, 1005-6.
2004: Alexander Bruskin; Igor Sivaev; Mikael Persson; Hans Lundqvist; Jörgen Carlsson; Stefan Sjöberg; Vladimir Tolmachev
Radiobromination of monoclonal antibody using potassium [76Br] (4 isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI).
Nuclear medicine and biology 2004;31(2):205-11.
2004: Vladimir Tolmachev; Jörgen Carlsson; Hans Lundqvist
A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclides.
Acta oncologica (Stockholm, Sweden) 2004;43(3):264-75.
2003: Asa Liljegren Sundberg; Ylva Almqvist; Anna Orlova; Erik Blomquist; Holger J Jensen; Lars Gedda; Vladimir Tolmachev; Jörgen Carlsson
Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF.
European journal of nuclear medicine and molecular imaging 2003;30(10):1348-56.
2003: Jörgen Carlsson; Emma Håkansson; Veronika Eriksson; Jan Grawe; Kenneth Wester; Erik Grusell; Anders Montelius; Hans Lundqvist
Early effects of low dose-rate radiation on cultured tumor cells.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):663-70.
2003: Asa Liljegren Sundberg; Anna Orlova; Alexander Bruskin; Lars Gedda; Jörgen Carlsson; Erik Blomquist; Hans Lundqvist; Vladimir Tolmachev
[(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):643-54.
2003: Erika Bohl Kullberg; Jörgen Carlsson; Katarina Edwards; Jacek Capala; Stefan Sjöberg; Lars Gedda
Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy.
International journal of oncology 2003;23(2):461-7.
2003: Asa Liljegren Sundberg; Ylva Almqvist; Vladimir Tolmachev; Jörgen Carlsson
Treatment of cultured glioma cells with the EGFR-TKI gefitinib ("Iressa", ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibition.
European journal of nuclear medicine and molecular imaging 2003;30(5):727-9.
2003: Asa Liljegren Sundberg; Erik Blomquist; Jörgen Carlsson; Ann-Charlott Steffen; Lars Gedda
Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran.
Nuclear medicine and biology 2003;30(3):303-15.
2003: Jörgen Carlsson; Erika Bohl Kullberg; Jacek Capala; Stefan Sjöberg; Katarina Edwards; Lars Gedda
Ligand liposomes and boron neutron capture therapy.
Journal of neuro-oncology 2003;62(1-2):47-59.
2003: Jörgen Carlsson; Eva Forssell-Aronsson; Sven-Ola Hietala; Torgny Stigbrand; Jan Tennvall
Tumour therapy with radionuclides: assessment of progress and problems.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;66(2):107-17.
2003: Ingela Turesson; Jörgen Carlsson; Anders Brahme; Bengt Glimelius; Björn Zackrisson; Bo Stenerlöw
Biological response to radiation therapy.
Acta oncologica (Stockholm, Sweden) 2003;42(2):92-106.
2003: Karl-Axel Johansson; Sören Mattsson; Anders Brahme; Jörgen Carlsson; Björn Zackrisson; Ingela Turesson
Radiation therapy dose delivery.
Acta oncologica (Stockholm, Sweden) 2003;42(2):85-91.
2002: Erika Bohl Kullberg; Nill Bergstrand; Jörgen Carlsson; Katarina Edwards; Markus Johnsson; Stefan Sjöberg; Lars Gedda
Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents.
Bioconjugate chemistry 2002;13(4):737-43.
2002: Pär Olsson; V Peter Collins; Lu Liu; Lars Gedda; Asa Liljegren; Jörgen Carlsson
Internalisation and retention of EGF-dextran associated radioactivity in transfected Chinese hamster ovary cells expressing the human EGF-receptor.
International journal of oncology 2002;20(5):1057-63.
2002: Linda Ohman; Lars Gedda; Göran Hesselager; Rolf Larsson; Monica Nister; Torgny Stigbrand; Kenneth Wester; Jörgen Carlsson
A new antibody recognizing the vIII mutation of human epidermal growth factor receptor.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2002;23(2):61-9.
2002: Jörgen Carlsson; Eva Forssell-Aronsson; Bengt Glimelius
Radiation therapy through activation of stable nuclides.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):629-34.
2002: Jörgen Carlsson; Eva Forssell-Aronsson; Bengt Glimelius; Sören Mattsson
Therapy with radiopharmaceuticals.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):623-8.
2002: Björn Zackrisson; Elisabeth Kjellén; Bengt Glimelius; Jörgen Carlsson; Bo Littbrand; Ingela Turesson
Sensitizing and protective substances in radiation therapy and predictive assays.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):615-22.
2002: Sören Mattsson; Anders Brahme; Jörgen Carlsson; Juliana Denekamp; Eva Forssell-Aronsson; Mikael Hellström; Karl-Axel Johansson; Elisabeth Kjellén; Bo Littbrand; Bo Nordenskjöld; Bo Stenerlöw; Ingela Turesson; Björn Zackrisson; Bengt Glimelius
Swedish Cancer Society radiation therapy research investigation.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):596-603.
2002: B Stenerlow; E Hoglund; Jörgen Carlsson
DNA fragmentation by charged particle tracks.
Advances in space research : the official journal of the Committee on Space Research (COSPAR) 2002;30(4):859-63.
2002: Kenneth Wester; Anna Sjöström; Manuel de la Torre; Jörgen Carlsson; Per-Uno Malmstrom
HER-2--a possible target for therapy of metastatic urinary bladder carcinoma.
Acta oncologica (Stockholm, Sweden) 2002;41(3):282-8.
2001: Peter Frisk; Amer Yaqob; K Nilsson; Jörgen Carlsson; Ulf Lindh
Influence of selenium on mercuric chloride cellular uptake and toxicity indicating protection: studies on cultured K-562 cells.
Biological trace element research 2001;81(3):229-44.
2001: P Nilsson; Lars Gedda; Anna Sjöström; Jörgen Carlsson
Effects of dextranation on the uptake of peptides in micrometastases: studies on binding of EGF in tumor spheroids.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(4):229-38.
2000: Peter Frisk; Amer Yaqob; K Nilsson; Jörgen Carlsson; Ulf Lindh
Uptake and retention of selenite and selenomethionine in cultured K-562 cells.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 2000;13(3):209-15.
2000: Anna Sjöström; P Bue; Per-Uno Malmstrom; Jörgen Carlsson
Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroids.
International journal of oncology 2000;17(3):559-64.
2000: Lars Gedda; H Ghaneolhosseini; P Nilsson; K Nyholm; Jean Pettersson; Stefan Sjöberg; Jörgen Carlsson
The influence of lipophilicity on binding of boronated DNA-intercalating compounds in human glioma spheroids.
Anti-cancer drug design 2000;15(4):277-86.
2000: Peter Frisk; Amer Yaqob; K Nilsson; Jörgen Carlsson; Ulf Lindh
Differences in the growth inhibition of cultured K-562 cells by selenium, mercury or cadmium in two tissue culture media (RPMI-1640, Ham's F-10).
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 2000;13(2):101-11.
2000: Bo Stenerlöw; Erik Höglund; Jörgen Carlsson; Erik Blomquist
Rejoining of DNA fragments produced by radiations of different linear energy transfer.
International journal of radiation biology 2000;76(4):549-57.
2000: Erik Höglund; Erik Blomquist; Jörgen Carlsson; Bo Stenerlöw
DNA damage induced by radiation of different linear energy transfer: initial fragmentation.
International journal of radiation biology 2000;76(4):539-47.
2000: T Hartman; Hans Lundqvist; Jan-Erik Westlin; Jörgen Carlsson
Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies.
International journal of radiation oncology, biology, physics 2000;46(4):1025-36.
1999: J Sundin; Vladimir Tolmachev; Jacek Koziorowski; Jörgen Carlsson; Hans Lundqvist; Sydney Welt; Steven M Larson; Anders Sundin
High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T.
Nuclear medicine and biology 1999;26(8):923-9.
1999: Q Zhao; Vladimir Tolmachev; Jörgen Carlsson; Hans Lundqvist; J Sundin; Jan-Christer Janson; Anders Sundin
Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF.
Bioconjugate chemistry 1999;10(6):938-46.
1999: Bo Stenerlöw; Erik Höglund; Jörgen Carlsson
Induction and rejoining of large DNA fragments after ion irradiation.
Radiation research 1999;151(6):642-8.
1999: Vladimir Tolmachev; Jacek Koziorowski; Igor Sivaev; Hans Lundqvist; Jörgen Carlsson; Anna Orlova; Lars Gedda; Pär Olsson; Stefan Sjöberg; Anders Sundin
Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution.
Bioconjugate chemistry 1999;10(3):338-45.
1999: A Lövqvist; Hans Lundqvist; Mark Lubberink; Vladimir Tolmachev; Jörgen Carlsson; Anders Sundin
Kinetics of 76Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties.
Medical physics 1999;26(2):249-58.
1999: Nina Tilly; Anders Brahme; Jörgen Carlsson; B Glimelius
Comparison of cell survival models for mixed LET radiation.
International journal of radiation biology 1999;75(2):233-43.
1999: Mark Lubberink; Hans Lundqvist; Jan-Erik Westlin; Vladimir Tolmachev; H Schneider; A Lövqvist; Anders Sundin; Jörgen Carlsson
Positron emission tomography and radioimmunotargeting--aspects of quantification and dosimetry.
Acta oncologica (Stockholm, Sweden) 1999;38(3):343-9.
1999: Hans Lundqvist; Mark Lubberink; Vladimir Tolmachev; A Lövqvist; Anders Sundin; Soheir Beshara; Alexander Bruskin; Jörgen Carlsson; Jan-Erik Westlin
Positron emission tomography and radioimmunotargeting--general aspects.
Acta oncologica (Stockholm, Sweden) 1999;38(3):335-41.
1999: Jörgen Carlsson; Erik Blomquist; Lars Gedda; A Liljegren; Per-Uno Malmstrom; Anna Sjöström; Anders Sundin; Jan-Erik Westlin; Q Zhao; Vladimir Tolmachev; Hans Lundqvist
Conjugate chemistry and cellular processing of EGF-dextran.
Acta oncologica (Stockholm, Sweden) 1999;38(3):313-21.
1998: Pär Olsson; Lars Gedda; Helena M Goike; Lu Liu; V Peter Collins; J Pontén; Jörgen Carlsson
Uptake of a boronated epidermal growth factor-dextran conjugate in CHO xenografts with and without human EGF-receptor expression.
Anti-cancer drug design 1998;13(4):279-89.
1998: P Bue; Kenneth Wester; Anna Sjöström; A Holmberg; Sten Nilsson; Jörgen Carlsson; Jan-Erik Westlin; C Busch; Per-Uno Malmstrom
Expression of epidermal growth factor receptor in urinary bladder cancer metastases.
International journal of cancer. Journal international du cancer 1998;76(2):189-93.
1998: Haile Mahteme; A Lövqvist; Wilhelm Graf; Hans Lundqvist; Jörgen Carlsson; Anders Sundin
Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases.
Anticancer research 1998;18(2A):843-8.
1998: Pär Olsson; M Black; Jacek Capala; Jeffrey A Coderre; T Hartman; M Makar; J Malmquist; Jean Pettersson; Nina Tilly; Stefan Sjöberg; Jörgen Carlsson
Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells.
International journal of radiation biology 1998;73(1):103-12.
1997: Lars Gedda; M Silvander; Stefan Sjöberg; Werner Tjarks; Jörgen Carlsson
Cytotoxicity and subcellular localization of boronated phenanthridinium analogues.
Anti-cancer drug design 1997;12(8):671-85.
1997: Q Zhao; Ingo Gottschalk; Jörgen Carlsson; L E Arvidsson; Sven Oscarsson; A Medin; Bo Ersson; Jan-Christer Janson
Preparation and purification of an end to end coupled mEGF-dextran conjugate.
Bioconjugate chemistry 1997;8(6):927-34.
1997: Peter Frisk; A Saetre; B Couce; Bo Stenerlöw; Jörgen Carlsson; Ulf Lindh
Effects of Pb2+, Ni2+, Hg2+ and Se4+ on cultured cells. Analysis of uptake, toxicity and influence on radiosensitivity.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 1997;10(4):263-70.
1997: A Lövqvist; Anders Sundin; A Roberto; Håkan Ahlström; Jörgen Carlsson; Hans Lundqvist
Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(7):1029-35.
1997: Stefan Sjöberg; Jörgen Carlsson; H Ghaneolhosseini; Lars Gedda; T Hartman; J Malmquist; C Naeslund; Pär Olsson; Werner Tjarks
Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy.
Journal of neuro-oncology 1997;33(1-2):41-52.
1997: A Lövqvist; Anders Sundin; Håkan Ahlström; Jörgen Carlsson; Hans Lundqvist
Pharmacokinetics and experimental PET imaging of a bromine-76-labeled monoclonal anti-CEA antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):395-401.
1997: Anna Sjöström; P Bue; Per-Uno Malmstrom; Sten Nilsson; Jörgen Carlsson
Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell lines.
International journal of cancer. Journal international du cancer 1997;70(4):383-9.
1996: Bo Stenerlöw; Erik Blomquist; Erik Grusell; T Hartman; Jörgen Carlsson
Rejoining of DNA double-strand breaks induced by accelerated nitrogen ions.
International journal of radiation biology 1996;70(4):413-20.
1996: M Essand; P Lögdahl; S Nilsson; Maria Wartenberg; Helmut Acker; Jörgen Carlsson
Retention and processing of the monoclonal anti-prostate E4 antibody after binding to prostatic adenocarcinoma DU 145 cells.
Cancer immunology, immunotherapy : CII 1996;43(1):39-43.
1996: Lars Gedda; Pär Olsson; J Pontén; Jörgen Carlsson
Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy.
Bioconjugate chemistry 1996;7(5):584-91.
1996: N Tilly; Pär Olsson; T Hartman; Jeffrey A Coderre; M Makar; J Malmquist; Stefan Sjöberg; J Pettersson; Jörgen Carlsson; Bengt Glimelius
In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;38(1):41-50.
1996: C Grönvik; Jacek Capala; Jörgen Carlsson
The non-variation in radiosensitivity of different proliferative states of human glioma cells.
Anticancer research 1996;16(1):25-31.
1995: M Essand; C Grönvik; T Hartman; Jörgen Carlsson
Radioimmunotherapy of prostatic adenocarcinomas: effects of 131I-labelled E4 antibodies on cells at different depth in DU 145 spheroids.
International journal of cancer. Journal international du cancer 1995;63(3):387-94.
1995: Bo Stenerlöw; O A Pettersson; M Essand; Erik Blomquist; Jörgen Carlsson
Irregular variations in radiation sensitivity when the linear energy transfer is increased.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;36(2):133-42.
1995: Jörgen Carlsson; Bo Stenerlöw; K R Russell; Erik Grusell; BS Larsson; Erik Blomquist
Cell type dependent effectiveness of tumour cell inactivation by radiation with increased ionisation density.
Anticancer research 1995;15(2):273-82.
1995: A Lövqvist; Anders Sundin; Håkan Ahlström; Jörgen Carlsson; Hans Lundqvist
76Br-labeled monoclonal anti-CEA antibodies for radioimmuno positron emission tomography.
Nuclear medicine and biology 1995;22(1):125-31.
1994: Jörgen Carlsson; Lars Gedda; C Grönvik; T Hartman; Anton Lindström; P Lindström; Hans Lundqvist; A Lövqvist; J Malmqvist; Pär Olsson
Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor.
International journal of radiation oncology, biology, physics 1994;30(1):105-15.
1994: Bo Stenerlöw; Jörgen Carlsson; Erik Blomquist; K Erixon
Clonogenic cell survival and rejoining of DNA double-strand breaks: comparisons between three cell lines after photon or He ion irradiation.
International journal of radiation biology 1994;65(6):631-9.
1994: T Hartman; Jörgen Carlsson
Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;31(1):61-75.
1994: I Gáti; Mats Bergström; Carin Muhr; Jörgen Carlsson
Leukotriene and 5-lipoxygenase inhibitor induced variations in thymidine uptake in a human glioma cell line cultured as monolayers or as multicellular spheroids.
Anticancer research 1994;14(2A):453-9.
1994: Pär Olsson; Anton Lindström; Jörgen Carlsson
Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells.
International journal of cancer. Journal international du cancer 1994;56(4):529-37.
1994: P Lindström; Pär Olsson; J Malmqvist; J Pettersson; P Lemmen; B Werner; Stefan Sjöberg; A Olin; Jörgen Carlsson
New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
Anti-cancer drugs 1994;5(1):43-52.
1994: Jörgen Carlsson; T Hartman; Erik Grusell
Dose enhancement in fast neutron tumour therapy due to neutron captures in 10B.
Acta oncologica (Stockholm, Sweden) 1994;33(3):315-22.
1994: O A Pettersson; Pär Olsson; P Lindström; Stefan Sjöberg; BS Larsson; Jörgen Carlsson
Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
Acta oncologica (Stockholm, Sweden) 1994;33(6):685-91.
1994: Jacek Capala; Helmut Acker; Anton Lindström; Jörgen Carlsson
Effects of epidermal growth factor receptor blocking in cultured glioma spheroids.
Anticancer research 1994;14(1A):45-53.
1993: O A Pettersson; Pär Olsson; P Lindström; Stefan Sjöberg; Jörgen Carlsson
Penetration and binding of L- and D-carboranylalanine in human melanoma spheroids.
Melanoma research 1993;3(5):369-76.
1993: M Essand; S Nilsson; Jörgen Carlsson
Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
Anticancer research 1993;13(5A):1261-8.
1993: Erik Blomquist; K R Russell; Bo Stenerlöw; A Montelius; Erik Grusell; Jörgen Carlsson
Relative biological effectiveness of intermediate energy protons. Comparisons with 60Co gamma-radiation using two cell lines.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;28(1):44-51.
1993: A Lövqvist; H Emanuelsson; J Nilsson; Hans Lundqvist; Jörgen Carlsson
Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives.
Journal of internal medicine 1993;233(3):215-26.
1993: B Rosengren; L Wulff; E Carlsson; Jörgen Carlsson; K G Strid; A Montelius
Backscatter radiation at tissue-titanium interfaces. Biological effects from diagnostic 65 kVp x-rays.
Acta oncologica (Stockholm, Sweden) 1993;32(1):73-7.
1993: Anders Sundin; Håkan Ahlström; L Carlsson; Wilhelm Graf; Bengt Glimelius; Jörgen Carlsson
Radioimmunolocalization of hepatic metastases and subcutaneous xenografts from a human colonic cancer in the nude rat. Aspects of tumour implantation site and mode of antibody administration.
Acta oncologica (Stockholm, Sweden) 1993;32(7-8):877-85.
1993: A Lövqvist; Anton Lindström; Jörgen Carlsson
Binding, internalization and excretion of TGF alpha-dextran associated radioactivity in cultured human glioma cells.
Cancer biotherapy 1993;8(4):345-56.
1993: Anton Lindström; Jörgen Carlsson
Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin.
Cancer biotherapy 1993;8(2):145-58.
1992: A Andersson; Jacek Capala; Jörgen Carlsson
Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.
Journal of neuro-oncology 1992;14(3):213-23.
1992: Helmut Acker; G Holtermann; B Bölling; Jörgen Carlsson
Influence of glucose on metabolism and growth of rat glioma cells (C6) in multicellular spheroid culture.
International journal of cancer. Journal international du cancer 1992;52(2):279-85.
1992: O A Pettersson; Jörgen Carlsson; Erik Grusell
Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
Cancer research 1992;52(6):1587-91.
1992: Erik Blomquist; Jörgen Carlsson
Strategy for planned radiotherapy of malignant gliomas: postoperative treatment with combinations of high dose proton irradiation and tumor seeking radionuclides.
International journal of radiation oncology, biology, physics 1992;22(2):259-63.
1992: Jörgen Carlsson; Stefan Sjöberg; BS Larsson
Present status of boron neutron capture therapy.
Acta oncologica (Stockholm, Sweden) 1992;31(8):803-13.
1991: G Frykholm; Bengt Glimelius; S Richter; Jörgen Carlsson
Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1991;27A(12):900-6.
1991: I Gáti; Mats Bergström; Carin Muhr; Bengt Långström; Jörgen Carlsson
Application of (methyl-11C)-methionine in the multicellular spheroid system.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(12):2258-65.
1991: Jacek Capala; Jörgen Carlsson
Influence of chloroquine and lidocaine on retention and cytotoxic effects of [131I]EGF: studies on cultured glioma cells.
International journal of radiation biology 1991;60(3):497-510.
1991: Sven Oscarsson; Jörgen Carlsson
Immunocomplex-immobilization technique.
The Analyst 1991;116(8):787-91.
1991: I Gáti; Mats Bergström; Carin Muhr; Jörgen Carlsson
Effects of the PAF-analog and -antagonist CV-6209 on cultured human glioma cell lines.
Prostaglandins, leukotrienes, and essential fatty acids 1991;43(2):103-10.
1991: E Szolgay-Daniel; Jörgen Carlsson; K Zierold; G Holtermann; E Dufau; Helmut Acker
Effects of amiloride treatment on U-118 MG and U-251 MG human glioma and HT-29 human colon carcinoma cells.
Cancer research 1991;51(3):1039-44.
1991: A Andersson; A Holmberg; Jörgen Carlsson; J Carlsson; Jan Pontén; Bengt Westermark
Binding of epidermal growth factor-dextran conjugates to cultured glioma cells.
International journal of cancer. Journal international du cancer 1991;47(3):439-44.
1991: S Scott-Robson; Jacek Capala; Jörgen Carlsson; P Malmborg; Hans Lundqvist
Distribution and stability in the rat of a 76Br/125I-labelled polypeptide, epidermal growth factor.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(2):241-6.
1991: B Rosengren; L Wulff; E Carlsson; Jörgen Carlsson; A Montelius; K Russell; Erik Grusell
Backscatter radiation at tissue-titanium interfaces. Analyses of biological effects from 60Co and protons.
Acta oncologica (Stockholm, Sweden) 1991;30(7):859-66.
1991: A Montelius; Erik Blomquist; P Naeser; A Brahme; Jörgen Carlsson; A C Carlsson; S Graffman; Erik Grusell; S Hallén; P Jakobsson
The narrow proton beam therapy unit at the the Svedberg Laboratory in Uppsala.
Acta oncologica (Stockholm, Sweden) 1991;30(6):739-45.
1990: Jacek Capala; M Pråhl; S Scott-Robson; J Pontén; B Westermark; Jörgen Carlsson
Effects of 131I-EGF on cultured human glioma cells.
Journal of neuro-oncology 1990;9(3):201-10.
1990: I Gáti; Mats Bergström; K Csóka; Carin Muhr; Jörgen Carlsson
Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines.
Prostaglandins, leukotrienes, and essential fatty acids 1990;40(2):117-24.
1990: I Gàti; Mats Bergström; G Westerberg; K Csòka; Carin Muhr; Jörgen Carlsson
Effects of prostaglandin and leukotriene inhibitors on the growth of human glioma spheroids.
European journal of cancer (Oxford, England : 1990) 1990;26(7):802-7.
1989: T Nylén; Helmut Acker; B Bölling; G Holterman; Jörgen Carlsson
Influence of ionizing radiation on oxygen profiles in different types of multicellular spheroids.
Radiation research 1989;120(2):213-26.
1989: Jörgen Carlsson; E Daniel-Szolgay; G Frykholm; Bengt Glimelius; A Hedin; B Larsson
Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids.
Cancer immunology, immunotherapy : CII 1989;30(5):269-76.
1988: Jörgen Carlsson; Helmut Acker
Relations between pH, oxygen partial pressure and growth in cultured cell spheroids.
International journal of cancer. Journal international du cancer 1988;42(5):715-20.
1987: Helmut Acker; Jörgen Carlsson; G Holtermann; T Nederman; T Nylén
Influence of glucose and buffer capacity in the culture medium on growth and pH in spheroids of human thyroid carcinoma and human glioma origin.
Cancer research 1987;47(13):3504-8.
1983: T Nederman; Helmut Acker; Jörgen Carlsson
Penetration of substances into tumor tissue: a methodological study with microelectrodes and cellular spheroids.
In vitro 1983;19(6):479-88.
1983: Helmut Acker; G Holtermann; Jörgen Carlsson; T Nederman
Methodological aspects of microelectrode measurements in cellular spheroids.
Advances in experimental medicine and biology 1983;159():445-62.